Cosette Pharmaceuticals, Inc.

Pharma

Pipeline Programs↗

Distinct drugs in development (Preclinical–Phase 3)

Indications↗

Distinct diseases across all programs

Clinical Trials↗

All sponsored trials (all statuses)

Orange Book Patents

Across 2 drugs with upcoming expirations

Activity

Key Events

Jul 11, 2025TrialSingle Dose of Vyleesi in Lactating Female Subjects to Measure the Concentration of Bremelanotide in Breast Milk

Dec 22, 2020FDAEffient — EFFIENT

Jun 21, 2019FDAVyleesi (autoinjector) — VYLEESI (AUTOINJECTOR)

Apr 3, 2019FDAWelchol — WELCHOL

Mar 28, 2019FDAEffient — EFFIENT

Mar 9, 2018FDAEffient — EFFIENT

Details

Company Info

Company Overview

—

Mkt Cap

—

Revenue

—

Cash

Patent Expirations

3 patent groups across drugs · Source: FDA Orange Book

DrugExpires

Indocin3 patentsApr 23, 2030 Vyleesi (autoinjector)3 patentsNov 5, 2033 Vyleesi (autoinjector)Apr 29, 2041

Regulatory

Regulatory Timeline

20021 event

FDAApr 25

Benicar — BENICAR

Application NDA021286 (NDA)

20093 events

FDAOct 2

Welchol — WELCHOL

Application NDA022362 (NDA)

FDAJul 10

Effient — EFFIENT

Application NDA022307 (NDA)

FDAJul 10

Effient — EFFIENT

Application NDA022307

20102 events

FDADec 6

Effient — EFFIENT

Application NDA022307

FDAMar 17

Indocin — INDOMETHACIN

Application NDA022536 (NDA)

20111 event

FDASep 27

Effient — EFFIENT

Application NDA022307

20122 events

FDANov 30

Effient — EFFIENT

Application NDA022307

FDAMar 23

Effient — EFFIENT

Application NDA022307

20132 events

FDANov 19

Effient — EFFIENT

Application NDA022307

FDAOct 16

Effient — EFFIENT

Application NDA022307

20141 event

FDAFeb 24

Indocin — TIVORBEX

Application NDA204768 (NDA)

20151 event

FDAJul 7

Effient — EFFIENT

Application NDA022307

20162 events

FDAJul 12

Effient — EFFIENT

Application NDA022307

FDAJan 14

Effient — EFFIENT

Application NDA022307

20181 event

FDAMar 9

Effient — EFFIENT

Application NDA022307

20193 events

FDAJun 21

Vyleesi (autoinjector) — VYLEESI (AUTOINJECTOR)

Application NDA210557 (NDA)

FDAApr 3

Welchol — WELCHOL

Application NDA210895 (NDA)

FDAMar 28

Effient — EFFIENT

Application NDA022307

20201 event

FDADec 22

Effient — EFFIENT

Application NDA022307

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)